The effects of the hemodilution with the third generation 6%HES130/0.4/9(Voluven&reg;)

The effects of the hemodilution with the third generation 6%HES130/0.4/9(Voluven&reg;) - The effects of the hemodilution with the third generation 6%HES130/0.4/9(Voluven&reg;)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019945

Enrollment

Registered

2015-11-27

Start date

2015-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

blood sampling

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers

Exclusion criteria

Exclusion criteria: coagulation defects

Design outcomes

Primary

Measure	Time frame
coagulation parameters ACT,PT,APTT,Ht,platelet,Factor8,fibrinogen,AT3	—

Countries

Japan

Contacts

Public ContactKenta Nakao

Tenri Hospital Department of Anesthesia

ane086@osaka-med.ac.jp0743-63-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

The effects of the hemodilution with the third generation 6%HES130/0.4/9(Voluven&amp;reg;)